Evidence map›Paper›PMID 41487875›Full record

ArticleCureus2025

Evolving Nature of Tuberculosis in the Post-pandemic World.

Tamanna Bordoloi, Kiran Bala, Jaya Biswas, Neha Nityadarshini, Raunak Bir, Pawan Tiwari, Saurabh Mittal, Praveen Bharti, Anant Mohan, Urvashi Singh

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Tamanna BordoloiDepartment of Microbiology, All India Institute of Medical Sciences, New Delhi, New Delhi, IND.
Kiran BalaDepartment of Microbiology, All India Institute of Medical Sciences, New Delhi, New Delhi, IND.
Jaya BiswasDepartment of Microbiology, All India Institute of Medical Sciences, New Delhi, New Delhi, IND.
Neha NityadarshiniDepartment of Microbiology, All India Institute of Medical Sciences, New Delhi, New Delhi, IND.
Raunak BirDepartment of Microbiology, Employee's State Insurance Corporation (ESIC) Medical College and Hospital, Faridabad, IND.
Pawan TiwariDepartment of Pulmonary, Critical Care, and Sleep Medicine, All India Institute of Medical Sciences, New Delhi, New Delhi, IND.
Saurabh MittalDepartment of Pulmonary, Critical Care, and Sleep Medicine, All India Institute of Medical Sciences, New Delhi, New Delhi, IND.
Praveen BhartiDepartment of Medicine, Maulana Azad Medical College, New Delhi, IND.
Anant MohanDepartment of Pulmonary, Critical Care, and Sleep Medicine, All India Institute of Medical Sciences, New Delhi, New Delhi, IND.
Urvashi SinghDepartment of Microbiology, All India Institute of Medical Sciences, New Delhi, New Delhi, IND.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction Tuberculosis (TB) and COVID-19 are highly transmissible respiratory diseases. The sequel of development of active TB after COVID-19 disease has been hypothesized to increase due to many reasons. We aimed to explore the association between COVID-19 infection, COVID-19 vaccination, and the development of active TB and navigate any existing patterns if present. Materials and methods This prospective observational study was conducted over a span of one year in two hospitals. A total of 200 patients with suspected TB were recruited and divided into two groups: Group A (n=100) had previous infection with COVID-19, and Group B (n=100) had no previous COVID-19 disease. Diagnosis of TB was done from both pulmonary and extrapulmonary samples by microscopy using the Ziehl-Neelsen (ZN) technique for acid-fast bacilli, culture using the Mycobacteria Growth Indicator Tube-960 (MGIT-960) (Becton, Dickinson and Company, Sparks, Maryland, United States), and molecular assays such as the GeneXpert® MTB/RIF (Cepheid, Sunnyvale, California, United States). Epidemiological data, clinical picture, and their pattern of sequence of TB after COVID-19 vaccination and COVID-19 disease were investigated. Results

Indexed as

covid-19covid-19 vaccinationgenexpertimmune responsetuberculosis

Identifiers

PMID41487875
PMCPMC12759192

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.